peptide synthesizer multipep rs (INTAVIS Inc)
90
Structured Review
INTAVIS Inc
peptide synthesizer multipep rs
Peptide Synthesizer Multipep Rs, supplied by INTAVIS Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/multipep+rs+system/multipep+automated+peptide+synthesizer/us12281141-649-10-16
Average 90 stars, based on 1 article reviews
Peptide Synthesizer Multipep Rs, supplied by INTAVIS Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/multipep+rs+system/multipep+automated+peptide+synthesizer/us12281141-649-10-16
Average 90 stars, based on 1 article reviews
peptide synthesizer multipep rs - by Bioz Stars,
2026-11
90/100 stars
Images
Related Articles
Residue:Article Title: Methods for producing cyclic compounds comprising N-substituted amino acid residues Article Snippet: .. The resulting residue was purified by reverse-phase column chromatography (acetonitrile containing 0.1% formic acid/distilled water containing 0.1% formic acid) to afford Compound aa113 ((2S)-2-[ethyl(9H-fluoren-9-ylmethoxycarbonyl)amino]-3-(4-methylphenyl)propanoic acid (Fmoc-EtPhe(4-Me)-OH)) (4.4 g, 73% in two steps) LCMS (ESI) m/z=430 (M+H)+ Retention time: 0.95 minutes, (analysis condition: SQDFA05) The following elongation of Fmoc-Pro-OH (CAS No. 71989-31-6), Fmoc-Hph (4-CF3-35-F2)-OH (Compound aa134), Fmoc-MeGly-OH (CAS No. 77128-70-2), Fmoc-EtPhe(4-Me)-OH (Compound aa113), Fmoc-Aze(2)-OH (CAS No. 136552-06-2), Fmoc-MeAla-OH (CAS No. 84000-07-7), and Fmoc-Ile-OH (CAS No. 71989-23-6) was performed by an Fmoc solid-phase synthesis method using a Purification:Article Title: Methods for producing cyclic compounds comprising N-substituted amino acid residues Article Snippet: .. The resulting residue was purified by reverse-phase column chromatography (acetonitrile containing 0.1% formic acid/distilled water containing 0.1% formic acid) to afford Compound aa113 ((2S)-2-[ethyl(9H-fluoren-9-ylmethoxycarbonyl)amino]-3-(4-methylphenyl)propanoic acid (Fmoc-EtPhe(4-Me)-OH)) (4.4 g, 73% in two steps) LCMS (ESI) m/z=430 (M+H)+ Retention time: 0.95 minutes, (analysis condition: SQDFA05) The following elongation of Fmoc-Pro-OH (CAS No. 71989-31-6), Fmoc-Hph (4-CF3-35-F2)-OH (Compound aa134), Fmoc-MeGly-OH (CAS No. 77128-70-2), Fmoc-EtPhe(4-Me)-OH (Compound aa113), Fmoc-Aze(2)-OH (CAS No. 136552-06-2), Fmoc-MeAla-OH (CAS No. 84000-07-7), and Fmoc-Ile-OH (CAS No. 71989-23-6) was performed by an Fmoc solid-phase synthesis method using a Column Chromatography:Article Title: Methods for producing cyclic compounds comprising N-substituted amino acid residues Article Snippet: .. The resulting residue was purified by reverse-phase column chromatography (acetonitrile containing 0.1% formic acid/distilled water containing 0.1% formic acid) to afford Compound aa113 ((2S)-2-[ethyl(9H-fluoren-9-ylmethoxycarbonyl)amino]-3-(4-methylphenyl)propanoic acid (Fmoc-EtPhe(4-Me)-OH)) (4.4 g, 73% in two steps) LCMS (ESI) m/z=430 (M+H)+ Retention time: 0.95 minutes, (analysis condition: SQDFA05) The following elongation of Fmoc-Pro-OH (CAS No. 71989-31-6), Fmoc-Hph (4-CF3-35-F2)-OH (Compound aa134), Fmoc-MeGly-OH (CAS No. 77128-70-2), Fmoc-EtPhe(4-Me)-OH (Compound aa113), Fmoc-Aze(2)-OH (CAS No. 136552-06-2), Fmoc-MeAla-OH (CAS No. 84000-07-7), and Fmoc-Ile-OH (CAS No. 71989-23-6) was performed by an Fmoc solid-phase synthesis method using a Liquid Chromatography with Mass Spectroscopy:Article Title: Methods for producing cyclic compounds comprising N-substituted amino acid residues Article Snippet: .. The resulting residue was purified by reverse-phase column chromatography (acetonitrile containing 0.1% formic acid/distilled water containing 0.1% formic acid) to afford Compound aa113 ((2S)-2-[ethyl(9H-fluoren-9-ylmethoxycarbonyl)amino]-3-(4-methylphenyl)propanoic acid (Fmoc-EtPhe(4-Me)-OH)) (4.4 g, 73% in two steps) LCMS (ESI) m/z=430 (M+H)+ Retention time: 0.95 minutes, (analysis condition: SQDFA05) The following elongation of Fmoc-Pro-OH (CAS No. 71989-31-6), Fmoc-Hph (4-CF3-35-F2)-OH (Compound aa134), Fmoc-MeGly-OH (CAS No. 77128-70-2), Fmoc-EtPhe(4-Me)-OH (Compound aa113), Fmoc-Aze(2)-OH (CAS No. 136552-06-2), Fmoc-MeAla-OH (CAS No. 84000-07-7), and Fmoc-Ile-OH (CAS No. 71989-23-6) was performed by an Fmoc solid-phase synthesis method using a Electrical Source Imaging:Article Title: Methods for producing cyclic compounds comprising N-substituted amino acid residues Article Snippet: .. The resulting residue was purified by reverse-phase column chromatography (acetonitrile containing 0.1% formic acid/distilled water containing 0.1% formic acid) to afford Compound aa113 ((2S)-2-[ethyl(9H-fluoren-9-ylmethoxycarbonyl)amino]-3-(4-methylphenyl)propanoic acid (Fmoc-EtPhe(4-Me)-OH)) (4.4 g, 73% in two steps) LCMS (ESI) m/z=430 (M+H)+ Retention time: 0.95 minutes, (analysis condition: SQDFA05) The following elongation of Fmoc-Pro-OH (CAS No. 71989-31-6), Fmoc-Hph (4-CF3-35-F2)-OH (Compound aa134), Fmoc-MeGly-OH (CAS No. 77128-70-2), Fmoc-EtPhe(4-Me)-OH (Compound aa113), Fmoc-Aze(2)-OH (CAS No. 136552-06-2), Fmoc-MeAla-OH (CAS No. 84000-07-7), and Fmoc-Ile-OH (CAS No. 71989-23-6) was performed by an Fmoc solid-phase synthesis method using a Analysis:Article Title: Methods for producing cyclic compounds comprising N-substituted amino acid residues Article Snippet: .. The resulting residue was purified by reverse-phase column chromatography (acetonitrile containing 0.1% formic acid/distilled water containing 0.1% formic acid) to afford Compound aa113 ((2S)-2-[ethyl(9H-fluoren-9-ylmethoxycarbonyl)amino]-3-(4-methylphenyl)propanoic acid (Fmoc-EtPhe(4-Me)-OH)) (4.4 g, 73% in two steps) LCMS (ESI) m/z=430 (M+H)+ Retention time: 0.95 minutes, (analysis condition: SQDFA05) The following elongation of Fmoc-Pro-OH (CAS No. 71989-31-6), Fmoc-Hph (4-CF3-35-F2)-OH (Compound aa134), Fmoc-MeGly-OH (CAS No. 77128-70-2), Fmoc-EtPhe(4-Me)-OH (Compound aa113), Fmoc-Aze(2)-OH (CAS No. 136552-06-2), Fmoc-MeAla-OH (CAS No. 84000-07-7), and Fmoc-Ile-OH (CAS No. 71989-23-6) was performed by an Fmoc solid-phase synthesis method using a other:Article Title: The fast-evolving FIKK kinase family of Plasmodium falciparum can be inhibited by a single compound. Article Snippet: Briefly, peptide arrays were synthesized on an Intavis Article Title: Screening macrocyclic peptide libraries by yeast display allows control of selection process and affinity ranking Article Snippet: Peptides were synthetised using either a ResPepSLi or a Article Title: Supporting Information In-Plate Chemical Synthesis of Isopeptide-Linked SUMOylated Peptide Fluorescence Polarization Reagents for High-Throughput Screening of SENP Preferences Article Snippet: The synthesis was performed using an automated Article Title: Screening macrocyclic peptide libraries by yeast display allows control of selection process and affinity ranking. Article Snippet: Peptideswere synthetised using either a ResPepSLi or a Sequencing:Article Title: Polyclonal antibodies towards abrin and ricin-design and potential application for mass spectrometry-based analysis of human biosamples. Article Snippet: .. Peptides, covering the complete sequence of abrin-A or ricin with a length of 22 (abrin-A) or 17 (ricin) amino acid residues, were synthesized by a ResPep SL (Intavis) fully automated Synthesized:Article Title: Polyclonal antibodies towards abrin and ricin-design and potential application for mass spectrometry-based analysis of human biosamples. Article Snippet: .. Peptides, covering the complete sequence of abrin-A or ricin with a length of 22 (abrin-A) or 17 (ricin) amino acid residues, were synthesized by a ResPep SL (Intavis) fully automated Article Title: Improving cryo-EM grids for amyloid fibrils using interface-active solutions and spectator proteins Article Snippet: .. The peptides were synthesized on a 0.10 mmol scale using 9-fluorenylmethyloxy-carbonyl (Fmoc) chemistry with an Intavis Membrane:Article Title: Polyclonal antibodies towards abrin and ricin-design and potential application for mass spectrometry-based analysis of human biosamples. Article Snippet: .. Peptides, covering the complete sequence of abrin-A or ricin with a length of 22 (abrin-A) or 17 (ricin) amino acid residues, were synthesized by a ResPep SL (Intavis) fully automated Peptide Microarray:Article Title: Molecular basis for Gβγ-SNARE mediated inhibition of synaptic vesicle fusion. Article Snippet: .. Peptide array synthesis was performed using the |